EMA's #HealthNotHype Campaign Taps Social Media Creators to Counter GLP-1 Misinformation
SHERIDAN, WYOMING – April 12, 2026 – The European Medicines Agency has launched its first-ever social media campaign in partnership with content creators, deploying the hashtag #HealthNotHype to push verified information about GLP-1 receptor agonists directly into the platforms where misinformation about these medicines is most prevalent. The month-long campaign targets Instagram — chosen specifically because of the high volume of GLP-1 conversations circulating there — and recruits creators from seven EU member states who are predominantly healthcare professionals or nutrition experts. With obesity and diabetes rates climbing globally, and celebrity endorsements driving a surge of public interest in GLP-1 drugs well beyond clinical circles, the EMA is betting that credible voices embedded in social media feeds can counterbalance the spread of counterfeit products and dangerous misuse.
